Literature DB >> 19796758

Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.

Michael T Andreoli1, Margaux A Morrison, Ben J Kim, Ling Chen, Scott M Adams, Joan W Miller, Margaret M DeAngelis, Ivana K Kim.   

Abstract

PURPOSE: To examine the interaction of genotypic variation of 16 single-nucleotide polymorphisms (SNP) in the complement factor H (CFH) and LOC387715/ARMS2/HTRA1 loci with clinical characteristics of age-related macular degeneration (AMD).
DESIGN: Retrospective cohort study.
METHODS: Eighty-four patients with neovascular AMD were genotyped using direct sequencing or Sequenom iPLEX technology. The Fisher exact test, Cochran-Mantel-Haenszel statistics, and Mann-Whitney U test were used to assess the effect of each SNP with respect to the following phenotypic manifestations: age at diagnosis, gender, affected eye, study and fellow eye visual acuity at diagnosis and at last follow-up, study eye best acuity during follow-up, presence of large drusen and retinal pigment epithelium (RPE) hyperpigmentation in study and fellow eye, choroidal neovascularization (CNV) angiographic subtype (classic vs occult), CNV size, presence of wet AMD in fellow eye, presence of dry AMD in fellow eye, and smoking history.
RESULTS: Only SNPs in the LOC387715/ARMS2/HTRA1 (10q26) region were associated with disease phenotypes. The polymorphisms rs10664316 and rs1049331 were associated with a decreased risk of poor visual acuity during follow-up and at diagnosis; rs2672598 and rs2293870 were associated with a decreased risk of RPE hyperpigmentation; rs10664316 was associated with a decreased risk of RPE hyperpigmentation with large drusen in the study eye, but an increased risk of large drusen in the fellow eye; rs11200638 was associated with an increased risk of larger CNV; rs10490924 and rs11200638 were associated with younger age of diagnosis.
CONCLUSIONS: Several polymorphisms examined in the LOC387715/ARMS2/HTRA1 locus, but none in the CFH region, correlated with specific phenotypic attributes of AMD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796758      PMCID: PMC2787659          DOI: 10.1016/j.ajo.2009.07.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.

Authors:  Sepideh Zareparsi; Kari E H Branham; Mingyao Li; Sapna Shah; Robert J Klein; Jurg Ott; Josephine Hoh; Gonçalo R Abecasis; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2005-05-13       Impact factor: 11.025

3.  Meta-analysis of genome scans of age-related macular degeneration.

Authors:  Sheila A Fisher; Goncalo R Abecasis; Beverly M Yashar; Sepideh Zareparsi; Anand Swaroop; Sudha K Iyengar; Barbara E K Klein; Ronald Klein; Kristine E Lee; Jacek Majewski; Dennis W Schultz; Michael L Klein; Johanna M Seddon; Susan L Santangelo; Daniel E Weeks; Yvette P Conley; Tammy S Mah; Silke Schmidt; Jonathan L Haines; Margaret A Pericak-Vance; Michael B Gorin; Heidi L Schulz; Fabio Pardi; Cathryn M Lewis; Bernhard H F Weber
Journal:  Hum Mol Genet       Date:  2005-06-29       Impact factor: 6.150

4.  Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.

Authors:  Eric H Souied; Nicolas Leveziel; Florence Richard; Marie-Agnès Dragon-Durey; Gabriel Coscas; Gisèle Soubrane; Pascale Benlian; Veronique Fremeaux-Bacchi
Journal:  Mol Vis       Date:  2005-12-19       Impact factor: 2.367

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

7.  The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17.

Authors:  Matthew D Davis; Ronald E Gangnon; Li-Yin Lee; Larry D Hubbard; Barbara E K Klein; Ronald Klein; Frederick L Ferris; Susan B Bressler; Roy C Milton
Journal:  Arch Ophthalmol       Date:  2005-11

8.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

Authors:  Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

9.  The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-11       Impact factor: 5.258

10.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.

Authors:  M A Brantley; S L Edelstein; J M King; M R Plotzke; R S Apte; S M Kymes; A Shiels
Journal:  Eye (Lond)       Date:  2008-02-22       Impact factor: 3.775

View more
  21 in total

1.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.

Authors:  Yi Yu; Robyn Reynolds; Jesen Fagerness; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

Review 2.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

3.  Investigation of genetic base in the treatment of age-related macular degeneration.

Authors:  Kalliopi Gourgouli; Ioanna Gourgouli; Georgios Tsaousis; Sofia Spai; Maria Niskopoulou; Spiros Efthimiopoulos; Klea Lamnissou
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

4.  Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice.

Authors:  Alex Jones; Sandeep Kumar; Ning Zhang; Zongzhong Tong; Jia-Hui Yang; Carl Watt; James Anderson; Heather Fillerup; Manabu McCloskey; Ling Luo; Zhenglin Yang; Balamurali Ambati; Robert Marc; Chio Oka; Kang Zhang; Yingbin Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

5.  The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.

Authors:  Stephen G Schwartz; Anita Agarwal; Jaclyn L Kovach; Paul J Gallins; William Cade; Eric A Postel; Gaofeng Wang; Juan Ayala-Haedo; Kylee M Spencer; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

6.  Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Authors:  Daniel Ardeljan; Catherine B Meyerle; Elvira Agron; Jie Jin Wang; Paul Mitchell; Emily Y Chew; Jing Zhao; Arvydas Maminishkis; Chi-Chao Chan; Jingsheng Tuo
Journal:  Eur J Hum Genet       Date:  2013-02-20       Impact factor: 4.246

7.  Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study.

Authors:  Periasamy Sundaresan; Praveen Vashist; Ravilla D Ravindran; Ashwini Shanker; Dorothea Nitsch; Bareng A S Nonyane; Liam Smeeth; Usha Chakravarthy; Astrid E Fletcher
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

8.  Association of LIPC and advanced age-related macular degeneration.

Authors:  J Lee; J Zeng; G Hughes; Y Chen; S Grob; L Zhao; C Lee; M Krupa; J Quach; J Luo; J Zeng; X Wei; X Zhang; J Zhu; Y Duan; H Ferreyra; M Goldbaum; W Haw; P X Shaw; L Tang; K Zhang
Journal:  Eye (Lond)       Date:  2013-01-25       Impact factor: 3.775

9.  Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Maureen G Maguire; Gui-Shuang Ying; Glenn J Jaffe; Cynthia A Toth; Ebenezer Daniel; Juan Grunwald; Daniel F Martin; Stephanie A Hagstrom
Journal:  JAMA Ophthalmol       Date:  2016-06-01       Impact factor: 7.389

Review 10.  Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.

Authors:  Michael B Gorin
Journal:  Mol Aspects Med       Date:  2012-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.